Correlation Between BRIM Biotechnology and AVer Information

Can any of the company-specific risk be diversified away by investing in both BRIM Biotechnology and AVer Information at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BRIM Biotechnology and AVer Information into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BRIM Biotechnology and AVer Information, you can compare the effects of market volatilities on BRIM Biotechnology and AVer Information and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BRIM Biotechnology with a short position of AVer Information. Check out your portfolio center. Please also check ongoing floating volatility patterns of BRIM Biotechnology and AVer Information.

Diversification Opportunities for BRIM Biotechnology and AVer Information

0.76

Correlation Coefficient

BRIM Biotechnology  AVer Information

Poor diversification

The 3 months correlation between BRIM and AVer is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding BRIM Biotechnology and AVer Information in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AVer Information and BRIM Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BRIM Biotechnology are associated (or correlated) with AVer Information. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AVer Information has no effect on the direction of BRIM Biotechnology i.e., BRIM Biotechnology and AVer Information go up and down completely randomly.

Pair Corralation between BRIM Biotechnology and AVer Information

Assuming the 90 days trading horizon BRIM Biotechnology is expected to generate 0.9 times more return on investment than AVer Information. However, BRIM Biotechnology is 1.11 times less risky than AVer Information. It trades about -0.05 of its potential returns per unit of risk. AVer Information is currently generating about -0.06 per unit of risk. If you would invest  4,500  in BRIM Biotechnology on September 15, 2024 and sell it today you would lose (740.00) from holding BRIM Biotechnology or give up 16.44% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

BRIM Biotechnology  vs.  AVer Information

BRIM Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BRIM Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

AVer Information

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AVer Information has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with BRIM Biotechnology and AVer Information

The main advantage of trading using opposite BRIM Biotechnology and AVer Information positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BRIM Biotechnology position performs unexpectedly, AVer Information can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AVer Information will offset losses from the drop in AVer Information's long position.

The idea behind BRIM Biotechnology and AVer Information pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.